Literature DB >> 9085850

Surprising specificity of PKR binding to delta agent genomic RNA.

D A Circle1, O D Neel, H D Robertson, P A Clarke, M B Mathews.   

Abstract

A direct, ribonuclease T1 protection assay was employed to study the binding of a delta agent genomic RNA transcript containing the conserved domain to the double-stranded RNA- (dsRNA-) dependent protein kinase of mammalian cells, PKR (also known as DAI, p1-elF2, or p68 kinase). In a control reaction, this assay identified a major portion of the same PKR binding site in VA RNA as deduced previously using a footprinting technique (Clarke PA, Mathews MB, 1995, RNA 1:1-20). Although delta agent RNA contains extensive secondary structure throughout the conserved region, we found a remarkable specificity in its PKR binding. The same region was protected by intact PKR and by a 184-amino acid fragment thereof containing the two RNA-binding motifs (dsRBMs) but lacking kinase activity. Two specific opposed, continuous segments of delta agent RNA (extending about 65-70 bases) were obtained reproducibly. Each is more than twice as long as those protected in VA RNA (about 25 bases), suggesting the involvement of PKR dimers in delta RNA binding. The PKR-protected region of delta agent RNA also contains a characteristic tertiary structural element that may be involved in binding specificity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085850      PMCID: PMC1369495     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  24 in total

1.  A cis-acting element in the 3'-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR.

Authors:  F Osman; N Jarrous; Y Ben-Asouli; R Kaempfer
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

2.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain.

Authors:  D R Taylor; B Tian; P R Romano; A G Hinnebusch; M M Lai; M B Mathews
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Recognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2.

Authors:  Y Ben-Asouli; Y Banai; H Hauser; R Kaempfer
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

5.  Hepatitis C virus internal ribosome entry site RNA contains a tertiary structural element in a functional domain of stem-loop II.

Authors:  A J Lyons; J R Lytle; J Gomez; H D Robertson
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

6.  The ribosome binding site of hepatitis C virus mRNA.

Authors:  J R Lytle; L Wu; H D Robertson
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Domain interactions in adenovirus VAI RNA mediate high-affinity PKR binding.

Authors:  Katherine Launer-Felty; James L Cole
Journal:  J Mol Biol       Date:  2014-01-04       Impact factor: 5.469

8.  Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR.

Authors:  B Tian; R J White; T Xia; S Welle; D H Turner; M B Mathews; C A Thornton
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

9.  Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication.

Authors:  Dan Cao; Dirk Haussecker; Yong Huang; Mark A Kay
Journal:  RNA       Date:  2009-09-23       Impact factor: 4.942

Review 10.  Effects of length and location on the cellular response to double-stranded RNA.

Authors:  Qiaoqiao Wang; Gordon G Carmichael
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.